References
- Bessonova L, Taylor TH, Mehta RS, et al (2011). Risk of a second breast cancer associated with hormone-receptor and HER2/neu status of the first breast cancer. Cancer Epidemiol Biomarkers Prev, 20, 389-96. https://doi.org/10.1158/1055-9965.EPI-10-1016
- Garcia Fernandez A, Gimenez N, Fraile M, et al (2012). Survival and clinicopathological characteristics of breast cancer patient according to different tumour subtypes as determined by hormone receptor and Her2 immunohistochemistry. a single institution survey spanning 1998 to 2010. Breast, 21, 366-73. https://doi.org/10.1016/j.breast.2012.03.004
- Goldhirsch A, Wood WC, Coates AS, et al (2011). Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol, 22, 1736-47. https://doi.org/10.1093/annonc/mdr304
- Gordon PB, Goldenberg SL (1995). Malignant breast masses detected only by ultrasound. A retrospective review. Cancer, 76, 626-30. https://doi.org/10.1002/1097-0142(19950815)76:4<626::AID-CNCR2820760413>3.0.CO;2-Z
- Haffty BG, Yang Q, Reiss M, et al (2006). Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol, 24, 5652-7. https://doi.org/10.1200/JCO.2006.06.5664
- Houssami N, Ciatto S, Martinelli F, et al (2009). Early detection of second breast cancers improves prognosis in breast cancer survivors. Ann Oncol, 20, 1505-10. https://doi.org/10.1093/annonc/mdp037
- Kadivar M, Mafi N, Joulaee A, et al (2012). Breast cancer molecular subtypes and associations with clinicopathological characteristics in Iranian women, 2002- 2011. Asian Pac J Cancer Prev, 13, 1881-6. https://doi.org/10.7314/APJCP.2012.13.5.1881
- Kim HJ, Kwak JY, Choi JW, et al (2010). Impact of US surveillance on detection of clinically occult locoregional recurrence after mastectomy for breast cancer. Ann Surg Oncol, 17, 2670-6. https://doi.org/10.1245/s10434-010-1087-z
- Lowery AJ, Kell MR, Glynn RW, et al (2012). Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype. Breast Cancer Res Treat, 133, 831-41. https://doi.org/10.1007/s10549-011-1891-6
- Malone KE, Begg CB, Haile RW, et al (2010). Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2. J Clin Oncol, 28, 2404-10. https://doi.org/10.1200/JCO.2009.24.2495
- Najafi B, Anvari S, Roshan ZA (2013). Disease free survival among molecular subtypes of early stage breast cancer between 2001 and 2010 in Iran. Asian Pac J Cancer Prev, 14, 5811-6. https://doi.org/10.7314/APJCP.2013.14.10.5811
- Sorlie T, Perou CM, Tibshirani R, et al (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA, 98, 10869-74. https://doi.org/10.1073/pnas.191367098
- Spitale A, Mazzola P, Soldini D, et al (2009). Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland. Ann Oncol, 20, 628-35. https://doi.org/10.1093/annonc/mdn675
- Tun NM, Villani GM, Ong K (2011). Risk of having BRCA mutations in women with triple-negative breast cancer: a systematic review and meta-analysis. J Clin Oncol, 29, 160.
- van 't Veer LJ, Dai H, van de Vijver MJ, et al (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature, 415, 530-6. https://doi.org/10.1038/415530a
- Voduc KD, Cheang MC, Tyldesley S, et al (2010). Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol, 28, 1684-91. https://doi.org/10.1200/JCO.2009.24.9284
Cited by
- Correlation between Ki67 and Histological Grade in Breast Cancer Patients Treated with Preoperative Chemotherapy vol.15, pp.23, 2015, https://doi.org/10.7314/APJCP.2014.15.23.10277
- Outcomes and recurrence patterns according to breast cancer subtypes in Korean women vol.151, pp.1, 2015, https://doi.org/10.1007/s10549-015-3390-7
- Impact of Age, Tumor Size, Lymph Node Metastasis, Stage, Receptor Status and Menopausal Status on Overall Survival of Breast Cancer Patients in Pakistan vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.1019
- Contralateral Breast Cancer: a Clinico-pathological Study of Second Primaries in Opposite Breasts after Treatment of Breast Malignancy vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.1207
- Failure patterns according to molecular subtype in patients with invasive breast cancer following postoperative adjuvant radiotherapy: long-term outcomes in contemporary clinical practice vol.163, pp.3, 2017, https://doi.org/10.1007/s10549-017-4206-8
- Locoregional Recurrence Following Breast Cancer Surgery in the Trastuzumab Era: A Systematic Review by Subtype vol.24, pp.11, 2017, https://doi.org/10.1245/s10434-017-6021-1
- BMI, reproductive factors, and breast cancer molecular subtypes: A case-control study and meta-analysis vol.27, pp.4, 2017, https://doi.org/10.1016/j.je.2016.05.002